Calliditas' Kinpeygo Receives CHMP Backing For Kidney Disease By: Benzinga via Benzinga May 19, 2022 at 15:21 PM EDT The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) hasadopted a positive ... Read More >> Related Stocks: Calliditas Therapeutics Ab ADR